TLX — TELIX PHARMACEUTICAL LTD
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
As of Q3 2026, 71 SEC-registered investment managers reported holding TLX (TELIX PHARMACEUTICAL LTD) in their latest 13F filings, with a combined reported value of $58.49M across 5.33M shares. That is +5.0% by share count (+128.06K shares) versus the previous quarter, while reported value moved +0.2%. Ownership is concentrated: the five largest holders account for 65.9% of reported value and the top ten for 85.4%.
Compared with the prior quarter, 25 opened new positions, 22 added to existing stakes, 11 trimmed, 15 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q3 2026, not real-time trading.
Major shareholders of TELIX PHARMACEUTICAL LTD (TLX) include ARMISTICE CAPITAL, LLC, Fidelity Management & Research (FMR), BLAIR WILLIAM & CO/IL, ranked by reported 13F value among the 103 institutional holders on this page.
TLX is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 71 | 5.33M | $58.49M | +5.0% |
| Q2 2026 | 61 | 3.31M | $38.15M | -7.7% |
| Q1 2026 | 40 | 2.86M | $27.26M | +68.4% |
| Q4 2025 | 42 | 1.39M | $10.49M | +8.8% |
| Q3 2025 | 30 | 1.14M | $10.86M | +94.7% |
| Q2 2025 | 22 | 457.65K | $7.29M | +62.7% |
| Q1 2025 | 7 | 52.83K | $800.82K | -2.1% |
| Q4 2024 | 1 | 3.73K | $57.44K | — |
Over the 8 quarters shown, institutional share counts increased 142683% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q3 2025 (+94.7%).
Top Institutional Holders (Q3 2026) — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 1.67M | $18.32M | 0.25% | New | |
| 550.55K | $6.04M | 0.00% | Reduce | |
| 480.69K | $5.27M | 0.01% | Add | |
| 419.00K | $4.60M | 0.02% | New | |
| 392.00K | $4.30M | 0.20% | New | |
| 291.49K | $3.20M | 0.01% | Add | |
| 266.20K | $2.92M | 0.86% | Hold | |
| 204.16K | $2.24M | 0.01% | Add | |
| 164.51K | $1.80M | 0.01% | Hold | |
| 110.00K | $1.25M | 0.02% | Reduce | |
| 97.16K | $1.07M | 0.00% | Reduce | |
| 63.17K | $716.38K | 0.00% | Reduce | |
| 60.45K | $663.17K | 0.01% | Add | |
| 48.76K | $534.86K | 0.00% | Add | |
| 46.19K | $506.67K | 0.01% | Add | |
| 42.84K | $470.17K | 0.00% | Add | |
| 37.80K | $414.71K | 0.00% | Add | |
| 37.50K | $411.40K | 0.00% | Reduce | |
| 37.12K | $407.25K | 0.00% | New | |
| 33.15K | $363.61K | 0.01% | Add | |
| 29.94K | $328.46K | 0.00% | Reduce | |
| 28.50K | $312.64K | 0.00% | Add | |
| 25.78K | $282.83K | 0.01% | Add | |
| 20.24K | $222.03K | 0.00% | New | |
| 19.98K | $219.19K | 0.00% | New |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 561.21K | $6.47M | 0.00% | Reduce | |
| 284.21K | $3.28M | 0.01% | Reduce | |
| 284.21K | $3.28M | 0.01% | Reduce | |
| 266.20K | $3.07M | 0.86% | Hold | |
| 197.25K | $2.27M | 0.01% | Add | |
| 189.19K | $2.18M | 0.00% | New | |
| 165.98K | $1.91M | 0.00% | Add | |
| 164.40K | $1.90M | 0.01% | Hold | |
| 134.70K | $1.55M | 0.00% | Add | |
| 122.98K | $1.42M | 0.00% | New | |
| 115.00K | $1.30M | 0.02% | Reduce | |
| 102.42K | $1.18M | 0.01% | New | |
| 77.54K | $876.18K | 0.00% | Add | |
| 71.29K | $821.99K | 0.93% | Add | |
| 68.78K | $792.99K | 0.01% | Add | |
| 58.99K | $680.14K | 0.01% | Add | |
| 58.00K | $668.74K | 0.03% | New | |
| 37.09K | $427.59K | 0.00% | Reduce | |
| 36.10K | $416.23K | 0.03% | New | |
| 35.54K | $409.74K | 0.01% | New | |
| 33.39K | $384.98K | 0.00% | New | |
| 32.30K | $372.37K | 0.01% | Add | |
| 31.62K | $364.59K | 0.01% | New | |
| 25.64K | $295.00K | 0.00% | New | |
| 25.42K | $293.14K | 0.01% | Reduce |
Q1 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 564.76K | $5.40M | 0.00% | Add | |
| 541.27K | $5.18M | 0.28% | New | |
| 289.92K | $2.77M | 0.01% | Add | |
| 289.92K | $2.77M | 0.01% | Add | |
| 266.20K | $2.55M | 0.82% | Hold | |
| 174.41K | $1.67M | 0.01% | Add | |
| 164.40K | $1.57M | 0.01% | New | |
| 130.00K | $1.16M | 0.02% | New | |
| 116.44K | $1.11M | 0.00% | Add | |
| 57.35K | $513.84K | 0.00% | Reduce | |
| 43.45K | $415.34K | 0.00% | Add | |
| 34.87K | $333.73K | 0.00% | New | |
| 33.25K | $318.23K | 0.00% | Add | |
| 32.30K | $309.11K | 0.00% | Add | |
| 26.01K | $248.89K | 0.00% | Add | |
| 25.04K | $239.59K | 0.01% | Reduce | |
| 16.65K | $159.37K | 0.00% | Reduce | |
| 12.55K | $120.12K | 0.13% | New | |
| 12.00K | $114.84K | 0.00% | Add | |
| 10.03K | $96.00K | 0.00% | Add | |
| 9.82K | $94.00K | 0.00% | Reduce | |
| 1.92K | $18.37K | 0.00% | Hold | |
| 1.83K | $17.53K | 0.00% | Add | |
| 1.43K | $13.64K | 0.00% | New | |
| 125 | $9.86K | 0.00% | Reduce |
Q4 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 266.20K | $2.06M | 0.62% | Add | |
| 250.52K | $1.88M | 0.00% | Add | |
| 250.52K | $1.88M | 0.00% | Add | |
| 123.57K | $925.54K | 0.00% | Add | |
| 74.37K | $557.02K | 0.00% | Add | |
| 46.66K | $349.47K | 0.00% | Reduce | |
| 46.34K | $347.13K | 0.00% | Add | |
| 40.04K | $299.92K | 0.00% | Reduce | |
| 36.83K | $275.84K | 0.00% | New | |
| 36.58K | $274.00K | 0.00% | New | |
| 27.25K | $204.09K | 0.00% | New | |
| 25.29K | $189.39K | 0.01% | Reduce | |
| 23.00K | $172.25K | 0.00% | New | |
| 19.73K | $147.80K | 0.00% | Reduce | |
| 19.73K | $147.80K | 0.00% | Reduce | |
| 18.41K | $137.88K | 0.00% | New | |
| 18.14K | $135.88K | 0.00% | Reduce | |
| 17.65K | $132.22K | 0.00% | Add | |
| 14.80K | $110.84K | 0.00% | New | |
| 11.82K | $88.53K | 0.00% | New | |
| 10.79K | $80.79K | 0.00% | Add | |
| 3.09K | $23.11K | 0.00% | Add | |
| 1.96K | $14.71K | 0.00% | Reduce | |
| 1.92K | $14.38K | 0.00% | Reduce | |
| 1.61K | $12.04K | 0.00% | Reduce |
Q3 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 196.74K | $1.88M | 0.00% | New | |
| 196.74K | $1.88M | 0.00% | New | |
| 128.00K | $1.22M | 0.34% | New | |
| 118.48K | $1.13M | 0.00% | Add | |
| 114.62K | $1.10M | 0.00% | New | |
| 114.62K | $1.10M | 0.00% | New | |
| 72.99K | $698.53K | 0.00% | Add | |
| 48.57K | $464.84K | 0.00% | New | |
| 42.11K | $403.02K | 0.00% | Add | |
| 26.21K | $250.82K | 0.01% | Add | |
| 25.36K | $242.65K | 0.00% | New | |
| 18.38K | $175.88K | 0.00% | Reduce | |
| 11.64K | $111.00K | 0.00% | New | |
| 5.57K | $53.26K | 0.00% | Reduce | |
| 3.23K | $30.95K | 0.00% | Reduce | |
| 2.58K | $24.68K | 0.00% | Add | |
| 2.40K | $22.97K | 0.00% | New | |
| 2.15K | $20.58K | 0.00% | New | |
| 1.29K | $12.37K | 0.00% | New | |
| 1.21K | $11.54K | 0.00% | New | |
| 1.03K | $9.86K | 0.00% | Hold | |
| 5.18K | $3.32K | 0.00% | Hold | |
| 336 | $3.22K | 0.00% | Add | |
| 125 | $1.20K | 0.00% | Add | |
| 53 | $507 | 0.00% | New |
Q2 2025 — 22 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 188.99K | $3.04M | 0.46% | New | |
| 60.30K | $975.07K | 0.00% | New | |
| 42.09K | $680.62K | 0.00% | New | |
| 41.33K | $668.27K | 0.00% | New | |
| 35.10K | $564.11K | 0.00% | New | |
| 25.17K | $404.44K | 0.00% | Add | |
| 18.48K | $296.93K | 0.00% | New | |
| 13.50K | $216.94K | 0.00% | New | |
| 13.24K | $212.77K | 0.01% | New | |
| 6.12K | $98.36K | 0.00% | Add | |
| 4.40K | $70.74K | 0.00% | Reduce | |
| 1.20K | $19.28K | 0.00% | New | |
| 1.19K | $19.19K | 0.00% | Add | |
| 1.03K | $16.56K | 0.00% | New | |
| 5.18K | $3.79K | 0.00% | Hold | |
| 141 | $2.00K | 0.00% | New | |
| 67 | $1.08K | 0.00% | Reduce | |
| 45 | $723 | 0.00% | New | |
| 27 | $434 | 0.00% | New | |
| 21 | $337 | 0.00% | New | |
| 18 | $289 | 0.00% | New | |
| 10 | $161 | 0.00% | New |
New Positions (Q3 2026)
- ARMISTICE CAPITAL, LLC 1.67M sh · $18.32M
- FARALLON CAPITAL MANAGEMENT, L.L.C. 419.00K sh · $4.60M
- ArrowMark Colorado Holdings LLC 392.00K sh · $4.30M
- Balyasny Asset Management 37.12K sh · $407.25K
- Jain Global LLC 20.24K sh · $222.03K
- MILLENNIUM MANAGEMENT LLC 19.98K sh · $219.19K
- WoodTrust Financial Corp 17.00K sh · $186.00K
- Goldman Sachs Group 15.43K sh · $169.22K
- OAK ASSOCIATES LTD /OH/ 12.24K sh · $134.32K
- Calydon Capital 3.55K sh · $38.93K
- BERTHEL, FISHER & COMPANY FINANCIAL SERVICES, INC. 3.00K sh · $32.91K
- Superior Planning, LLC 1.31K sh · $14.41K
Fully Exited (vs previous quarter)
- Lazard Asset Management sold 284.21K sh · $3.28M
- Quadrature Capital Ltd sold 102.42K sh · $1.18M
- XY Capital Ltd sold 71.29K sh · $821.99K
- XTX Topco Ltd sold 68.78K sh · $792.99K
- NLB Skladi, upravljanje premozenja, d.o.o. sold 58.00K sh · $668.74K
- Capricorn Fund Managers Ltd sold 36.10K sh · $416.23K
- GTS SECURITIES LLC sold 35.54K sh · $409.74K
- JANE STREET GROUP, LLC sold 33.39K sh · $384.98K
- HRT FINANCIAL LP sold 25.64K sh · $295.00K
- Virtu Financial LLC sold 12.63K sh · $146.00K
- Blue Trust, Inc. sold 742 sh · $8.55K
- CVA Family Office, LLC sold 127 sh · $1.46K
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 1.67M | — | — | — | — | — | — | — |
| Fidelity Management & Research (FMR) | 550.55K | 561.21K | 564.76K | 123.57K | 118.48K | 42.09K | — | — |
| BLAIR WILLIAM & CO/IL | 480.69K | 122.98K | — | — | — | 13.50K | — | — |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | 419.00K | — | — | — | — | — | — | — |
| ArrowMark Colorado Holdings LLC | 392.00K | — | — | — | — | — | — | — |
| LAZARD ASSET MANAGEMENT LLC | 291.49K | 284.21K | 289.92K | 250.52K | 114.62K | — | — | — |
| PORTLAND INVESTMENT COUNSEL INC. | 266.20K | 266.20K | 266.20K | 266.20K | 128.00K | — | — | — |
| Private Advisor Group, LLC | 204.16K | 197.25K | 174.41K | 46.34K | 42.11K | 25.17K | 10.14K | — |
| Integrated Wealth Concepts LLC | 164.51K | 164.40K | 164.40K | — | — | — | — | — |
| Raiffeisen Bank International AG | 110.00K | 115.00K | 130.00K | — | — | — | — | — |
| UBS Group AG | 97.16K | 134.70K | 32.30K | 1.96K | 5.57K | 6.12K | 3.65K | 3.73K |
| JPMorgan Chase & Co | 63.17K | 77.54K | 57.35K | 74.37K | 25.36K | — | — | — |
| Vanguard Personalized Indexing Management, LLC | 60.45K | 58.99K | 33.25K | 18.14K | 18.38K | 18.48K | — | — |
| Orion Porfolio Solutions, LLC | 48.76K | 15.62K | — | — | — | — | — | — |
| SummitTX Capital, L.P. | 46.19K | 31.62K | — | — | — | — | — | — |
| Mariner, LLC | 42.84K | 37.09K | 43.45K | 36.58K | — | — | — | — |
| Two Sigma Investments | 37.80K | 10.23K | — | — | — | — | — | — |
| Marshall Wace | 37.50K | 189.19K | — | 46.66K | 48.57K | — | — | — |
| Balyasny Asset Management | 37.12K | — | — | — | — | — | — | — |
| IHT Wealth Management, LLC | 33.15K | 32.30K | 25.04K | 25.29K | 26.21K | 13.24K | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold TLX?
As of 2026-Q3, 71 institutional funds reported holding TLX (TELIX PHARMACEUTICAL LTD) in SEC 13F filings, with a combined reported value of $58.49M.
How many shares of TLX do institutions own?
13F filers reported 5.33M shares of TLX, worth $58.49M in aggregate at the end of 2026-Q3.
Is institutional ownership of TLX rising or falling?
Share counts moved +5.0% versus the prior quarter — accumulation.
Who are the top institutional holders of TLX?
The largest 13F holders are ARMISTICE CAPITAL, LLC, Fidelity Management & Research (FMR), BLAIR WILLIAM & CO/IL, FARALLON CAPITAL MANAGEMENT, L.L.C., ArrowMark Colorado Holdings LLC; the top 25 are ranked at the top of this page.
Who are the major shareholders of TELIX PHARMACEUTICAL LTD?
The major shareholders of TELIX PHARMACEUTICAL LTD (TLX) by reported 13F value are ARMISTICE CAPITAL, LLC, Fidelity Management & Research (FMR), BLAIR WILLIAM & CO/IL, FARALLON CAPITAL MANAGEMENT, L.L.C., ArrowMark Colorado Holdings LLC, among 103 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.